U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    CDKN2B cyclin dependent kinase inhibitor 2B [ Homo sapiens (human) ]

    Gene ID: 1030, updated on 25-Apr-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization.

    CDKN2A/B deletion in IDH-mutant astrocytomas: An evaluation by Fluorescence in-situ hybridization.
    Ranade M, Epari S, Shetty O, Dhanavade S, Chavan S, Sahay A, Sahu A, Shetty P, Moiyadi A, Singh V, Dasgupta A, Chatterjee A, Kannan S, Gupta T.

    03/29/2024
    Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.

    Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.
    Beihaghi M, Sahebi R, Beihaghi MR, Nessiani RK, Yarasmi MR, Gholamalizadeh S, Shahabnavaie F, Shojaei M., Free PMC Article

    03/18/2024
    TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis.

    TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis.
    Jiang B, Hu L, Dong D, Guo Z, Wei W, Wang C, Shao W, Ma T, Chen Y, Li Q, Hu W.

    11/3/2023
    Expression analysis of cytoskeleton regulator RNA and Cyclin Dependent Kinase Inhibitor 2B genes in breast cancer.

    Expression analysis of cytoskeleton regulator RNA and Cyclin Dependent Kinase Inhibitor 2B genes in breast cancer.
    Mokhtari M, Gholipour M, Eslami S, Abak A, Hussen BM, Rakhshan A, Ghafouri-Fard S.

    10/4/2023
    Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma.

    Loss of CDKN2A/B is a Molecular Marker of High-grade Histology and is Associated with Aggressive Behavior in Acinic Cell Carcinoma.
    Dogan S, Xu B, Rana S, Chen H, Ghossein RA, Berger MF, Ho AL, Katabi N.,

    09/12/2023
    Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.

    Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
    Ruan Y, Xie L, Zou A., Free PMC Article

    08/20/2023
    KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients.

    KIT A502_Y503 duplication mutation serves as a potential and universal target for neoantigen peptide in Chinese GIST patients.
    Liu F, Wang Q, Li Y, Li L, Shi J, Fan X, Pan Q, Li R.

    08/7/2023
    Joint Effects Between CDKN2B/P15 Methylation and Environmental Factors on the Susceptibility to Gastric Cancer.

    Joint Effects Between CDKN2B/P15 Methylation and Environmental Factors on the Susceptibility to Gastric Cancer.
    Zhou H, Nie C, Tian W, Han X, Wang J, Du X, Wang Q, Zhu X, Xiang G, Zhao Y.

    06/29/2023
    Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma.

    Translational significance of CDKN2A/B homozygous deletion in isocitrate dehydrogenase-mutant astrocytoma.
    Fortin Ensign SP, Jenkins RB, Giannini C, Sarkaria JN, Galanis E, Kizilbash SH., Free PMC Article

    01/28/2023
    PRMT6 functionally associates with PRMT5 to promote colorectal cancer progression through epigenetically repressing the expression of CDKN2B and CCNG1.

    PRMT6 functionally associates with PRMT5 to promote colorectal cancer progression through epigenetically repressing the expression of CDKN2B and CCNG1.
    Chen Y, Liang W, Du J, Ma J, Liang R, Tao M.

    01/14/2023
    Organochlorine pesticides may induce leukemia by methylation of CDKN2B and MGMT promoters and histone modifications.

    Organochlorine pesticides may induce leukemia by methylation of CDKN2B and MGMT promoters and histone modifications.
    Rafeeinia A, Asadikaram G, Moazed V, Darabi MK.

    12/3/2022
    Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.

    Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.
    Youn BJ, Cheong HS, Namgoong S, Kim LH, Baek IK, Kim JH, Yoon SJ, Kim EH, Kim SH, Chang JH, Kim SH, Shin HD.

    11/5/2022
    [The associations of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene polymorphisms with the risk of Crohn's disease in Chinese patients].

    [The associations of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene polymorphisms with the risk of Crohn's disease in Chinese patients].
    Xu Y, Shao XX, Hu DY, Rao SY, Xiao HY, Fang Y, Jiang Y.

    09/3/2022
    Methylation patterns of the CDKN2B and CDKN2A genes in an indigenous population exposed to pesticides.

    Methylation patterns of the CDKN2B and CDKN2A genes in an indigenous population exposed to pesticides.
    Paredes-Céspedes DM, Bernal-Hernández YY, Herrera-Moreno JF, Rojas-García AE, Medina-Díaz IM, González-Arias CA, Barrón-Vivanco BS.

    05/21/2022
    Reciprocal Regulation between lncRNA ANRIL and p15 in Steroid-Induced Glaucoma.

    Reciprocal Regulation between lncRNA ANRIL and p15 in Steroid-Induced Glaucoma.
    Wan P, Huang S, Luo Y, Deng C, Zhou J, Long E, Zhuo Y., Free PMC Article

    05/21/2022
    Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism.

    Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism.
    Journo S, Goldberg AK, Sokol ES, Zinger L, Pasmanik-Chor M, Sarvin B, Simkin D, Fuchs S, Shlomi T, Wolf I, Rubinek T.

    04/23/2022
    Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.

    Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study.
    Davari DR, Orlow I, Kanetsky PA, Luo L, Edmiston SN, Conway K, Parrish EA, Hao H, Busam KJ, Sharma A, Kricker A, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Sacchetto L, Dwyer T, Ollila DW, Begg CB, Berwick M, Thomas NE, GEM Study Group., Free PMC Article

    03/5/2022
    CDKN2B-AS1 gene rs4977574 A/G polymorphism and coronary heart disease: A meta-analysis of 40,979 subjects.

    CDKN2B-AS1 gene rs4977574 A/G polymorphism and coronary heart disease: A meta-analysis of 40,979 subjects.
    Li YY, Wang H, Zhang YY., Free PMC Article

    02/26/2022
    Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.

    Genetic association between CDKN2B/CDKN2B-AS1 gene polymorphisms with primary glaucoma in a North Indian cohort: an original study and an updated meta-analysis.
    Thakur N, Kupani M, Mannan R, Pruthi A, Mehrotra S., Free PMC Article

    01/15/2022
    MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.

    MicroRNA-497/195 is tumor suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
    Boldrin E, Gaffo E, Niedermayer A, Boer JM, Zimmermann M, Weichenhan D, Claus R, Münch V, Sun Q, Enzenmüller S, Seyfried F, Demir S, Zinngrebe J, Cario G, Schrappe M, Den Boer ML, Plass C, Debatin KM, Te Kronnie G, Bortoluzzi S, Meyer LH.

    12/25/2021
    NBR2 promotes the proliferation of glioma cells via inhibiting p15 expression.

    NBR2 promotes the proliferation of glioma cells via inhibiting p15 expression.
    Zhang J, Jiang H, Feng X, Wang L, Yang X.

    12/25/2021
    B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation.

    B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation.
    Chakraborty S, Martines C, Porro F, Fortunati I, Bonato A, Dimishkovska M, Piazza S, Yadav BS, Innocenti I, Fazio R, Vaisitti T, Deaglio S, Zamò A, Dimovski AJ, Laurenti L, Efremov DG.

    12/4/2021
    Circular ANRIL isoforms switch from repressors to activators of p15/CDKN2B expression during RAF1 oncogene-induced senescence.

    Circular ANRIL isoforms switch from repressors to activators of p15/CDKN2B expression during RAF1 oncogene-induced senescence.
    Muniz L, Lazorthes S, Delmas M, Ouvrard J, Aguirrebengoa M, Trouche D, Nicolas E., Free PMC Article

    12/4/2021
    Long Noncoding RNA GAS5 Targeting miR-221-3p/Cyclin-Dependent Kinase Inhibitor 2B Axis Regulates Follicular Thyroid Carcinoma Cell Cycle and Proliferation.

    Long Noncoding RNA GAS5 Targeting miR-221-3p/Cyclin-Dependent Kinase Inhibitor 2B Axis Regulates Follicular Thyroid Carcinoma Cell Cycle and Proliferation.
    Liu Y, Li YF, Liu J, Deng ZG, Zeng L, Zhou WB.

    11/13/2021
    Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma.

    Adverse histology, homozygous loss of CDKN2A/B, and complex genomic alterations in locally advanced/metastatic renal mucinous tubular and spindle cell carcinoma.
    Yang C, Cimera RS, Aryeequaye R, Jayakumaran G, Sarungbam J, Al-Ahmadie HA, Gopalan A, Sirintrapun SJ, Fine SW, Tickoo SK, Epstein JI, Reuter VE, Zhang Y, Chen YB., Free PMC Article

    10/23/2021
    firstprevious page of 13 nextlast